movingneedle_graphic.png

Are you frustrated with the time it takes to commercialize a drug?

So are we.

Do you wish you could decrease your study start-up timelines by up to 4 weeks? Take the guesswork out of supply forecasting? Make changes midstream without expensive trial delays?

Well, now you can.
MEET PRANCER, 4G’s robust, efficient approach to agile RTSM. 4G’s Prancer simplifies and accelerates randomization and trial supply management – delivering faster, more efficient and more reliable RTSM systems.

4G utilizes NLP to read, interpret and understand written specifications to build deployable systems automatically [more]

Evaluate and determine a supply strategy at the turn of a dial [more]

Put 4G’s experience, technical expertise and advisory services to work for you [more]

AWARDS

Great Places to Work 2017 - 2018
CIO Review Most Promising Pharma & Life Sciences Tech Solutions Providers 2017
Scrip Awarads Finalist 2017
4G'S PRANCER ENABLES US TO:
  • Address RTSM challenges that have plagued the industry for years.
  • Reduce the clinical trial timeline by accelerating study start-up.
  • Radically change the process for building clinical systems.
  • Remove the burden of managing hundreds of poorly understood parameters controlling supply forecasting.
  • Enhance visibility into your trials for informed decision-making.
RequestPresentation.png
DownloadData.png

100% Configurable, Robust Agile RTSM Functionality
Adapted to Your Processes and SOPs

Unparalleled level of features and functionality:
ServicesListGraphic.png
LearnMore_button.png
MapGraphic.png
We are RTSM pioneers, engineers and marketing experts. With over 200 years of combined industry experience from both sponsor and vendor organizations, we are committed to be your personal advisor in RTSM, supply strategy and execution.
meet_button.png

PRESS

Applied-Clinical-Trials-logo_white-9.png
Clinical Leader
Pharma Voice
clinicalInformaticsNews_white-3.png
CIO Review_alternative_white-2.png
DavidKelleher.png

"My reason for launching 4G is very simple. We must accelerate the speed of discovery. We must do whatever we can to ensure that vital medications get to those that need them as fast as we safely can."

David Kelleher, CEO